Walk for Breath Celebration
CSL Behring 5th Annual Walk for Breath Celebration
Join your fellow Alphas at the five-year anniversary the Walk for Breath Celebration
to be held at the Seattle Center's EMP (Experience Music Project) Museum. Immediately
following the walk, CSL Behring will be hosting an educational dinner for participants at the Seattle
Space Needle, located in the heart of the Seattle Center.
WHERE: EMP Museum- Seattle, Washington
WHEN: Thursday, June 7, 2012 at 3:30 pm
EVENT DETAILS: Registration for the walk will begin
at 2:00 pm at the Hyatt Regency Hotel. CSL Behring will provide transportation for
those wishing to attend the event. Buses will depart the Hyatt Regency at 3:00 pm.
The Walk for Breath Celebration was created to recognize and promote participation
in the My Steps For Healthy Living Program, a program that CSL Behring designed
exclusively to help Alphas walk their way toward a healthier lifestyle.
Before engaging in any physical activity, always consult with a doctor to make
sure the activity is right for you.
For questions regarding the Walk for Breath Celebration, please contact CSL Behring
Consumer Affairs Department at 1-866-936-2472.
If you would like to participate in the Walk for Breath Celebration, please
register now.
Please note that this event is limited to patients and their families only. Due
to numerous state and federal laws, we regret that we are unable to allow healthcare
professionals to attend.
Important Safety Information
Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira are not available.
Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.
In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).
Zemaira is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.
Please see full prescribing information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.